ASIC (ASIC) officer Schenk vests 21,981-share stock option at $10.66

Rhea-AI Filing Summary

Ategrity Specialty Insurance Co Holdings reported that officer Chris Schenk acquired a stock option award linked to 21,981 shares of common stock. The option has an exercise price of $10.66 per share and expires on January 1, 2032, with all 21,981 option shares held directly after this transaction.

According to the accompanying note, this vesting relates to a larger option originally granted on January 1, 2022 for 43,963 shares, of which 50% could vest based on performance over the 2024 and 2025 fiscal years. The company states those performance criteria were met, leading to vesting of 21,981 shares under the award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schenk Chris

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	21,981	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 21,981 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option shares acquired: 21,981 shares Exercise price: $10.66 per share Expiration date: January 1, 2032 +3 more

6 metrics

Option shares acquired 21,981 shares Stock option award to Chris Schenk

Exercise price $10.66 per share Strike price of reported stock option

Expiration date January 1, 2032 Option term end for this award

Total option shares after transaction 21,981 shares Direct holdings from this specific option

Original 2022 grant size 43,963 shares Initial option grant on January 1, 2022

Performance-eligible portion 50% of 43,963 shares Portion eligible to vest based on 2024–2025 results

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, performance criteria, vesting

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

performance criteria financial

"based on the Issuer's satisfaction of certain performance criteria for the two fiscal years"

vesting financial

"resulting in the vesting of the option as to 21,981 shares"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schenk Chris

(Last) (First) (Middle)

ATEGRITY SPECIALTY INSURANCE CO HOLDINGS

9 WEST 57TH STREET, 33RD FLOOR

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ategrity Specialty Insurance Co Holdings [ ASIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.66	03/05/2026		A		21,981		03/05/2026	01/01/2032	Common Stock	21,981	$0	21,981(1)	D

Explanation of Responses:

1. On January 1, 2022 the reporting person was granted an option to purchase 43,963 shares of common stock. 50% of the option was eligible to vest as of January 1, 2026 based on the Issuer's satisfaction of certain performance criteria for the two fiscal years immediately preceding the vesting date. The performance criteria for 2024 and 2025 were met, resulting in the vesting of the option as to 21,981 shares.

Remarks:

President, Chief Underwriting Officer

	/s/ Eric Crespolini, Attorney-in-Fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ASIC report for Chris Schenk on this Form 4?

ASIC reported that officer Chris Schenk acquired a stock option covering 21,981 shares of common stock. This is a compensation-related award rather than an open-market trade, and all 21,981 option shares are reported as held directly after the transaction.

What are the key terms of Chris Schenk’s ASIC stock option award?

The option reported for Chris Schenk covers 21,981 shares of ASIC common stock at an exercise price of $10.66 per share. It became exercisable in connection with performance vesting and carries an expiration date of January 1, 2032.

How does this 21,981-share option relate to Chris Schenk’s prior ASIC grant?

The footnote explains this vesting comes from an earlier option granted on January 1, 2022 for 43,963 shares. Half of that original option, or 21,981 shares, was eligible to vest based on performance criteria over the 2024 and 2025 fiscal years.

What performance conditions affected Chris Schenk’s ASIC option vesting?

The company states that 50% of the 2022 option could vest if certain performance criteria were met for the two fiscal years before vesting. ASIC reports that the criteria for 2024 and 2025 were satisfied, triggering vesting for 21,981 shares.

Is Chris Schenk’s ASIC Form 4 transaction a stock purchase or compensation grant?

The Form 4 classifies the event as a grant, award, or other acquisition of a derivative security, not an open-market purchase. It reflects performance-based vesting of an existing stock option, a common form of executive compensation, rather than a cash stock purchase.